Publications by authors named "J S Haselkorn"
Background: Fatigue is one of the most common and disabling symptoms of multiple sclerosis (MS). Behavioral interventions that target one or more behaviors such as sleep hygiene, exercise, energy management, cognitive processes, as well as mood have been shown to reduce fatigue in people with MS. Yet, little is known about mechanisms of intervention effects on MS fatigue.
View Article and Find Full Text PDFBackground: It is recommended that healthcare providers and persons with multiple sclerosis (MS) have discussions prior to discontinuing a disease modifying therapy (DMT). However, if these appointments missed, either as a no show (NS) or short-notice cancellation (SNC), these discussions do not take place and may result in premature discontinuation. This study aimed to explore whether appointment non-attendance was predictive of DMT persistence the following year.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to analyze chronic opioid use patterns among Veterans with spinal cord injury (SCI) and assess associated demographic and health factors from 2015 to 2017.
- Researchers found a decline in overall prescription opioid use during the study period, with chronic use rates of 33.2%, 31.7%, and 29.7%.
- Factors like past depression or COPD increased the odds of chronic opioid use, while non-white race and certain health issues like hyperlipidemia were linked to lower odds; however, previous opioid prescriptions strongly predicted current use.
Background: Persons with multiple sclerosis (PwMS) can experience deficits in prospective memory (PM) or "remembering to remember," which are associated with functional difficulties. However, no cognitive rehabilitation intervention has specifically addressed improving PM in PwMS. The Telehealth PM Intervention (TPMI) provides a novel combination of two strategies-visual imagery and implementation intentions-that have each been beneficial in other populations.
View Article and Find Full Text PDFBackground: Cognitive dysfunction and brain atrophy are both common in progressive multiple sclerosis (MS) but are seldom examined comprehensively in clinical trials. Antioxidant treatment may affect the neurodegeneration characteristic of progressive MS and slow its symptomatic and radiographic correlates.
Objectives: This study aims to evaluate cross-sectional associations between cognitive battery components of the Brief International Cognitive Assessment for Multiple Sclerosis with whole and segmented brain volumes and to determine if associations differ between secondary progressive (SPMS) and primary progressive (PPMS) MS subtypes.